“…In patients with HIV infection, serum antibody responses to C. jejuni are markedly impaired compared to immunocompetent controls (Perlman et al 1988). Similarly, systemic disease, such as bacteremia, due to Campylobacter species is mainly seen in immunocompromized individuals (Pigrau et al 1997;Schonheyder, Sogaard, and Frederiksen 1995;Melamed et al 1988;Melamed et al 1983). Certainly, antibodies directed against Campylobacter promote bacterial agglutination and complement activation (Jones, Eldridge, and Dale 1980;, have bactericidal activity (Blaser, Smith, and Kohler 1985;Johnson et al 1984;Pennie et al 1986) and may display opsonic activity promoting uptake and killing by professional phagocytes (Walan et al 1992;Bernatowska et al 1989; Bar, Glenn-Calvo, and Krausse 1991).…”